Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial
PMID: 39637881
Source: Lancet Gastroenterol Hepatol
Publication date:
2025-07-24
Year:
2025
Abstract
NULL